EX-23.1 4 adms10k2017ex231.htm EXHIBIT 23.1

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-214409) and Form S-8 (Nos. 333-216313, 333-210255, 333-202467 and 333-195384) of Adamas Pharmaceuticals, Inc. of our report dated February 22, 2018 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP 

San Jose, California

February 22, 2018